Influenza in the Family
- 2 November 2000
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 343 (18) , 1331-1332
- https://doi.org/10.1056/nejm200011023431808
Abstract
Infectious diseases often spread among the members of a family. Many such diseases spread mainly to susceptible children and only to a lesser degree to older family members who have been exposed to the organism. With influenza, however, the concept that the spread of infection starts with school-age children in the family has been supported by a number of studies.1 The introduction of neuraminidase inhibitors into clinical practice has led to new options for the prevention of influenza. As a group, the neuraminidase inhibitors are well tolerated and are active against both influenza A and B viral strains, and resistance . . .Keywords
This publication has 8 references indexed in Scilit:
- Inhaled Zanamivir for the Prevention of Influenza in FamiliesNew England Journal of Medicine, 2000
- Zanamivir for treatment of symptomatic influenza A and B infection in children five to twelve years of age: a randomized controlled trialThe Pediatric Infectious Disease Journal, 2000
- Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trialThe Lancet, 2000
- Respiratory Distress Associated with ZanamivirNew England Journal of Medicine, 2000
- New Options for the Prevention of InfluenzaNew England Journal of Medicine, 1999
- Use of the Selective Oral Neuraminidase Inhibitor Oseltamivir to Prevent InfluenzaNew England Journal of Medicine, 1999
- A New Antiviral Agent for Influenza — Is There a Clinical Niche?New England Journal of Medicine, 1997
- Efficacy and Safety of the Neuraminidase Inhibitor Zanamivir in the Treatment of Influenzavirus InfectionsNew England Journal of Medicine, 1997